Professional Documents
Culture Documents
com
Original Article
Abstract
Mouth dissolving tablets are solid dosage forms containing drugs that disintegrate in the oral cavity within less than one minute
leaving an easy-to-swallow residue. In the recent trend the development of mouth dissolving tablets formulation is emerging
and gaining popularity because it is easy to administer and leads to better patient compliance. These dosage forms are placed in
the mouth, allowed to disperse or dissolve in the saliva. The release the drug as soon as they come in contact with the saliva,
thus obviating the need for water during administration. The aim of this article is to review the progress of the evolving
technologies and super disintegrating agents in the formulation, manufacturing and evaluation of these tablets.This article also
discusses the new evaluation methodologies for these orally disintegrating tablets. Various modifications in the conventional
evaluation and use of specialized instruments are found to be essential in the testing of these dosage forms. In the present
review the formulation techniques and different technologies are discussed.
© 2011 Universal Research Publications. All rights reserved
Key words: Mouth dissolving tablet, Conventional techniques, Rapid Disintegration
readily (e.g. urea, ammonium carbonate, ammonium removed via sublimation, which generates porous structures.
bicarbonate, hexa methelene tetramine, camphor etc.) were Additionally, several solvents (e.g. cyclohexane, benzene)
added to the other tablet ingredients and the mixture is can be also used as pore forming agents.
compressed into tablets. The volatile materials were then
International Journal of Pharmaceutical and Clinical Science 2011; 1 (1): 1-8
3
Table No.2: Relationship between % compressibility and flow ability
% Compressibility Flow ability
5 – 12 Excellent
12 – 16 Good
18 – 21 Fair Passable
23 – 35 Poor
33 – 38 Very Poor
< 40 Very Very Poor
1 < 20 Excellent
2 20 – 30 Good
3 30 – 34 Passable
4 > 34 Very Poor
80 mg or less ±10
More than 80 mg but less than 250 mg ±7.5
250 mg or more ±5
f = (1- W0 / W) × 100
Conclusion:
Where, W0 is weight of the tablets before the test and W is Mouth dissolving Tablets is the general form of nomenclature
the weight of the tablet after the test. for tablets that disintegrate rapidly or instantly in the oral
cavity. MDTs have better patient acceptance and compliance
International Journal of Pharmaceutical and Clinical Science 2011; 1 (1): 1-8
7
and may offer improved biopharmaceutical properties, promethazine theoclate Mouth dissolving tablets; The
improved efficacy, and better safety compared with Indian pharmacist., 65- 68.
conventional oral dosage forms. MDTs can be prepared in 5. Prajapati G.B., Patel S.B., (2010)., Formulation,
different ways and product performance depends upon the Evaluation and Optimization of Orally Disintegrating
drug suitability and excipients selections in the delivery Tablet of Piroxicam; International Journal of PharmTech
system. In combination with other technologies such as Research., 1893-1899.
modified release and microencapsulation, MDTs will 6. Mohan A. and Ghosh S.K., (2010)., Fast Dissolving
continue to provide enhanced commercial and therapeutic Tablets: Past, Present and Future; Indian drug 47(6).,5-
benefits. MDT is a growing technology, offering considerable 11.
benefits for lifecycle management16, development timelines, 7. Sharma S., (2008)., New generation of tablet: Fast
patient convenience and market share. By paying close dissolving tablet; Latest review Vol VI .
attention to advances in technologies, pharmaceutical 8. Kumari S., Visht S., Sharma P.K., Yadav R.K., (2010).,
companies can take advantage of MDTs for product line ex- Fast dissolving Drug delivery system : Review Article;
tensions or for first-to-market products. With continued Journal of Pharmacy Research 3(6).,1444-1449.
development of new pharmaceutical excipients, one can 9. C. Kumaresan., (2008)., Orally Disintegrating Tablet -
expect the emergence of more novel technologies for MDTs Mouth dissolving, Sweet Taste, And Target Release
in the days to come. The successful marketed MDTs have Profile; Pharmaceutical review Vol-6.
good taste and rapid release properties. With rapid acceptance 10. Solanki A.B., Parikh J.R., Parikh R.H., (2007).,
of MDTs by patients and pharmaceutical companies, the Formulation and Optimization of Piroxicam Proniosomes
market for this dosage form is promising, and the product by 3-Factor, 3-Level Box-Behnken Design; AAPS
pipeline continues to grow rapidly. PharmSciTech. 8(4).
11. Sinko. J. Patrick Martins., Physical pharmacy and
Acknowledgement(s): Pharmaceutical science, 5th edition distributed by B.I.
Mr. Sohel Harsoliya would like to acknowledge the support Publication PVT Ltd., 232.
during this review from Research Scholar, JJT university, 12. Patel S.S., Pate M.S., Patel N.M., (2009)., Flowability
Rajasthan & J.K.Pathan for its esteemed support and testing of directly compressible excipients accordind to
encouragement. british pharmacopoeia; Journal of Pharmaceutical
Research Vol. 8. 66 -69.
References: 13. D. Bhowmik et al., ( 2009)., Fast Dissolving Tablet: An
1. S. J.R., Nayak S., Amlan S., Deep V.V., Khemariya P., Overview; Journal of Chemical and Pharmaceutical
Sumbhate S., Nayak S.,(2009)., Taste masking of Research.,163-177.
Lornoxicam by polymer carrier system and formulation 14. O.M. Javier, Hong M., M.G. Aubey, T.M. Jason.,
of oral disintegrating tablets; International Journal of (2010)., Orally Disintegrating Tablets using starch and
Drug Delivery., 27-31. fructose; Pharmaceutical Technology.,92-99.
2. Fu Yourong , Yang S., Jeong S. H., Kimura S., & Park 15. Shaikh S et al., (2010)., Formulation and evaluation of
K., (2004)., Therapeutic Drug Carrier Systems, Orally orodispersible tablets of piroxicam.,IJPI’s Journal of
Fast Disintegrating Tablets:Developments, Pharmaceutics and Cosmetology., 2-8.
Technologies,Taste-Masking and Clinical 16. Panigrahi R., Behera S.,( 2010)., A Review On Fast
Studies;Critical Reviews™ 21(6).,433–475. Dissolving Tablets., WebmedCentral Quality and patient
3. Chaudhari P.D., Chaudhari S.P., Lanke S.D. and Patel safety WMC00809., 1-15.
N.,( 2007)., Formulation and in vitro evaluation of teste 17. Mahaveer Pr. Khinchi., (2010)., Orally disintegrating
masked orodispersible dosage form of Levocetirizine tablets: A future prospectus., Int J Pharm Sci Bio., 71-79.
dihydrochloride; Indian journal of pharmacuitical 18. Modasiya M.K. et al., (2009)., Design and
Education and research 41(4).,319-327. Characterization of Fast Disintegrating Tablets of
4. Nayak U.K., Patra S.K., Rout P.K., Patro B.K. and Piroxicam., International Journal of PharmTech
Nayak B.S., (2008)., Development and optimization of Research., 353-357.